Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,723.95
(
-1.69%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,040.13
(
-3.93%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biotech jim post# 161400

Wednesday, 05/22/2013 4:46:18 PM

Wednesday, May 22, 2013 4:46:18 PM

Post# of 257257
MRK—Nice call on the 20mg Suvorexant dose. Given the panel votes today (#msg-88202674, #msg-88207202), the 15mg and 20mg doses would seem to be in good shape with the FDA.

I'm glad the panel didn't support a new clinical trial on a (probably subtherapeutic) 10mg dose, which would've been a waste of time, IMO. The vote on that question was 10-5 against.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now